What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging resonates in the US? How do you prepare for launch in a market as diverse as the US?
In this live Global Whispers webinar, Louise Maddison (Senior Consultant – Global Market Access, Mtech Access – Powered by Petauri) will interview some of our colleagues from Petauri Advisors who are either former payers, or former industry market access leads in the US. Join Louise on Wednesday 26th March at 4.00pm (GMT)/5.00pm (CET)/9.00am (PDT)/12.00pm (EDT) as she puts your questions to:
- Rory Davies – Vice President of Value and Access, Petauri Advisors, with extensive past experience in Chief Clinical roles at Cigna, Flipt and WellDyne
- Dan Vanderpoel – Executive Vice President, Strategic Payer Marketing; Head, Client Solutions, Petauri and former Manager, Trade Relations at Humana
- Shana Gunderson Hua – Vice President of Value and Access, Petauri Advisors and former Medical Affairs Executive Director at Genentech and former AVP of Pharmaceutical Strategy and Contracting at Cigna and Express Scripts (now Evernorth)
In this Global Whispers webinar, we will explore what global market access teams need to know about market access and payer engagement in the US. We will explore how and why value messaging, pricing, and launch strategies are developed differently for the US market, compared to other key launch markets, and what this means for global teams preparing for US launch or taking a US-developed proposition internationally.
To do this, we are delighted to welcome guest speakers from the Petauri Advisors and ACE team; an in-house team of former US access decision makers, with experience across all areas of US healthcare, including Medicare, Medicaid, and Commercial.
Rory, Dan, and Shana will together enable us to gain a broad, yet deep, view of the US market, from both the payer and industry perspective.
We will explore:
- What you need to know about the nuances of launching in the US market
- What US payers need to hear about your product
- How to craft value messaging that resonates with the US market
- Key differences between the US and other global markets with regard to access, customer engagement, and pricing strategies
- What these differences mean for global and local teams
- Opportunities and challenges when launching new medicines/medical devices/diagnostics in the US
More about our speakers
Rory Davies – Vice President of Value and Access, Petauri Advisors, with extensive past experience in Chief Clinical roles at Cigna, Flipt, and WellDyne
Rory has over 20 years of healthcare experience, most of which has been spent overseeing formulary decisions for health plans. As the Chief Pharmacy Officer at Cigna Healthcare, he and his team were responsible for nearly $10 billion in annual medical and pharmacy spend and helped secure $750 million in savings by deploying traditional and non-traditional tools to reduce costs and improve member experience. Rory led the integration of medical and pharmacy data to demonstrate the value of medicine within the Cigna population, and he aligned the value assessment committees of Cigna and ESI post-acquisition. Rory earned his Doctor of Pharmacy at the University of Utah and resides in Chattanooga, Tennessee.
Dan Vanderpoel – Executive Vice President, Strategic Payer Marketing; Head, Client Solutions, Petauri; and former Manager, Trade Relations at Humana
With over 20 years of vast and diverse market access experience, Dan has honed his expertise through a variety of leadership roles at various payer and pharmaceutical services organizations. At Humana, Dan served on the company’s Formulary Strategy Team and P&T Committee, with sole responsibility for negotiation, implementation, and management of all Medicare rebate agreements. Dan made the transition to pharmaceutical service providers at The Hobart Group, in 2012. Most recently, Dan served as SVP, Managing Director at Precision Value and Health, where he navigated the complexities of value and access on behalf of hundreds of clients, contributing to the company’s continued growth and success.
Shana Gunderson Hua – Vice President of Value and Access, Petauri Advisors; and former Medical Affairs Executive Director at Genentech
As the Medical Affairs Executive Director at Genentech, Shana led high-impact medical and market access engagements with organized customers such as national payers, PBMs, and health systems. Prior to her tenure at Genentech, Shana was the AVP of Pharmaceutical Strategy and Contracting at Cigna and Express Scripts (now Evernorth). She spearheaded all medical rebate contract negotiations across medical benefit products, including complex treatments like cell and gene therapy, biosimilars, and medical value-based agreements. Shana also founded Innovative Pharmacy Solutions LLC, where she was at the forefront of oncology market access innovation.
We invite you to put your questions to our guest speakers in this session. Please suggest a question when you register.
If you cannot attend the webinar but would like to know more, please register nonetheless, as all registrants will receive a recording of the webinar.
The webinar is free and open to all market access, HEOR, strategic, and commercial teams in Pharmaceutical, Medtech, and Diagnostics companies. We also welcome attendees from healthcare systems. Some colleagues from other organisations may attend at the discretion of Mtech Access and Petauri.
The Global Whispers webinar series
This webinar is part of our Global Whispers series where we explore global market access trends and challenges facing the Pharmaceutical and Medtech industries and offer insights into key launch markets.
Our previous webinars are available on demand:
- ‘Navigating US payer evidence needs to optimise market access’ with Petauri colleagues Nicole Lodowski and Bob Nordyke
- ‘De-mystifying the NHS – What you need to know about the NHS as a market for your health technology’ with guest speaker Dr Faris Al-Ramadani (PCN Clinical Director and GP Partner in the NHS and HealthTech and Venture Capital Consultant)
- ‘Market access and reimbursement in Canada – changes at CADTH’ with guest speaker Don Husereau (Adjunct Professor of Medicine, The University of Ottawa)
- ‘Setting your product up for success – commercialisation strategy for the US market’ with guest speaker Janice MacLennan (Pharma and Medtech brand strategist and founder of NMBLR)
- ‘Market Access in Italy: Exploring the potential impact of the AIFA reforms’ with guest speaker Prof. Fabrizio Gianfrate (Professor of HEOR and Ex-Payer)
- ‘Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access’ with guest speaker George Magrath (CEO, Lexitas)
- ‘Market access in the German-speaking markets’ with guest speaker Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH)
- ‘Market access for digital therapies and digital medicines’ with guest speaker Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze)
- ‘A global market access journey: What it takes to bring a cannabinoid pharmaceutical to market’ with guest speaker Michael Sassano (CEO – SOMAÍ Pharmaceuticals)
